Back to Search

A Multicenter, Open-label, Phase 1 Study Evaluating the Safety and Tolerability of HMPL-760 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Other Non-Hodgkin Lymphoma (NHL)

  • Protocol Number: 202111009
  • Principal Investigator: Kahl, Brad
  • Cancer Types: Leukemia, Myeloma, and Hematologic, Lymphoma

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions